Search
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Particle Engineering for Inhaled Therapeutics
Pharmaceutical Technology Europe, February 2014
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting
Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services.
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Analytical Characterization
Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Hovione sells the iMAX business
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.